Turn Therapeutics (NASDAQ:TTRX) Posts Quarterly Earnings Results

Turn Therapeutics (NASDAQ:TTRX) released its earnings results on Thursday. The company reported ($0.07) earnings per share (EPS) for the quarter, Zacks reports.

Turn Therapeutics Stock Down 2.7%

TTRX stock traded down $0.11 during mid-day trading on Friday, hitting $3.98. 51,101 shares of the stock were exchanged, compared to its average volume of 912,557. Turn Therapeutics has a 12 month low of $3.65 and a 12 month high of $26.50.

Insider Activity at Turn Therapeutics

In related news, insider Abraham Chesed bought 14,286 shares of the company’s stock in a transaction that occurred on Thursday, October 23rd. The stock was bought at an average cost of $4.60 per share, for a total transaction of $65,715.60. Following the acquisition, the insider directly owned 1,447,268 shares of the company’s stock, valued at $6,657,432.80. The trade was a 1.00% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Turn Therapeutics Company Profile

We are a pharmaceutical and medical device development company built around a proprietary platform technology designed to enhance drug performance. Our patented mixing process — commercially referred to as PermaFusion™ (“PermaFusion”) — enables stable suspension of polar, water-soluble active pharmaceutical ingredients (“APIs”) in oil-based carriers without the use of emulsifiers.